Cargando…

Impact of the 2019 Food and Drug Administration Guidance for Uncomplicated Urinary Tract Infection on Treatment Response Rates: A Reanalysis of a Clinical Trial of Nitrofurantoin vs Fosfomycin

BACKGROUND: Current US Food and Administration (FDA) guidance recommends that the primary efficacy endpoint for uncomplicated urinary tract infection (uUTI) clinical trials be a composite of clinical and microbiological responses. We applied these criteria to a previous clinical trial to determine t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grant, Rebecca, Büchler, Andrea, Flight, William, Huang, Chun, Ferrinho, Diogo, Janmohamed, Salim, Mulgirigama, Aruni, Godycki-Cwirko, Maciek, Leibovici, Leonard, Huttner, Angela, Harbarth, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661658/ https://www.ncbi.nlm.nih.gov/pubmed/38023546 http://dx.doi.org/10.1093/ofid/ofad557

Ejemplares similares

Risk factors for treatment failure in women with uncomplicated lower urinary tract infection
por: Martischang, Romain, et al.
Publicado: (2021)

Real-Life Comparison of Fosfomycin to Nitrofurantoin for the Treatment of Uncomplicated Lower Urinary Tract Infection in Women
por: Shafrir, Asher, et al.
Publicado: (2023)

Fosfomycin versus Nitrofurantoin for the Treatment of Lower UTI in Outpatients
por: Sharma, Shraddha, et al.
Publicado: (2021)

Design of Two Phase III, Randomized, Multicenter Studies Comparing Gepotidacin with Nitrofurantoin for the Treatment of Uncomplicated Urinary Tract Infection in Female Participants
por: Perry, Caroline, et al.
Publicado: (2022)

A systematic scoping review of faropenem and other oral penems: treatment of Enterobacterales infections, development of resistance and cross-resistance to carbapenems
por: Gandra, Sumanth, et al.
Publicado: (2022)

Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae
por: Tulara, Neeraj Kumar
Publicado: (2018)

Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in Escherichia coli Isolated in Clinical Urine Samples
por: Sorlozano-Puerto, Antonio, et al.
Publicado: (2020)

The delivery of prevention programmes for cardiovascular disease and chronic obstructive pulmonary disease in Lodz by primary care physicians
por: Godycki-Ćwirko, Maciek, et al.
Publicado: (2010)

Nitrofurantoin: what is the evidence for current UK guidance?
por: Kashouris, Eleanor, et al.
Publicado: (2023)

A survey of patient behaviours and beliefs regarding antibiotic self-medication for respiratory tract infections in Poland
por: Muras, Magdalena, et al.
Publicado: (2012)

Quaternary prevention: reviewing the concept: Quaternary prevention aims to protect patients from medical harm
por: Martins, Carlos, et al.
Publicado: (2018)

Community determinants of COPD exacerbations in elderly patients in Lodz province, Poland: a retrospective observational Big Data cohort study
por: Kowalczyk, Anna, et al.
Publicado: (2022)

O02 Nitrofurantoin: what is the evidence for current guidance?
por: Kashouris, Eleanor, et al.
Publicado: (2023)

Is Telemedicine in Primary Care a Good Option for Polish Patients with Visual Impairments Outside of a Pandemic?
por: Binder-Olibrowska, Katarzyna Weronika, et al.
Publicado: (2022)

“To Be Treated as a Person and Not as a Disease Entity”—Expectations of People with Visual Impairments towards Primary Healthcare: Results of the Mixed-Method Survey in Poland
por: Binder-Olibrowska, Katarzyna Weronika, et al.
Publicado: (2022)

Susceptibility of Escherichia coli from Community-Acquired Urinary Tract Infection to Fosfomycin, Nitrofurantoin, and Temocillin in Korea
por: Seo, Mi-Ran, et al.
Publicado: (2014)

Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections: Consensus Guidance Using a Modified Delphi Process
por: Heil, Emily L, et al.
Publicado: (2021)

Community determinants of COPD exacerbations in elderly patients in Poland: protocol for a retrospective Big Data observational cohort study
por: Zakowska, Izabela, et al.
Publicado: (2019)

A checklist-based method for improving COPD care for the elderly in general practice: study protocol for a cluster randomized controlled trial using electronic health records
por: Kowalczyk, Anna, et al.
Publicado: (2021)

Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review
por: Stapleton, Ann E., et al.
Publicado: (2020)

Developing a research agenda for patient safety in primary care. Background, aims and output of the LINNEAUS collaboration on patient safety in primary care
por: Esmail, Aneez, et al.
Publicado: (2015)

Evaluation of a tailored implementation strategy to improve the management of patients with chronic obstructive pulmonary disease in primary care: a study protocol of a cluster randomized trial
por: Godycki-Cwirko, Maciek, et al.
Publicado: (2014)

Multiple-Dose Oral Fosfomycin for Treatment of Complicated Urinary Tract Infections in the Outpatient Setting
por: Derington, Catherine G, et al.
Publicado: (2020)

Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections
por: Amladi, Anushree Ulhas, et al.
Publicado: (2019)

Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis
por: Zhanel, George G., et al.
Publicado: (2016)

Clinical Risk Scores to Predict Nonsusceptibility to Trimethoprim-Sulfamethoxazole, Fluoroquinolone, Nitrofurantoin, and Third-Generation Cephalosporin Among Adult Outpatient Episodes of Complicated Urinary Tract Infection
por: Lodise, Thomas P, et al.
Publicado: (2023)

Nitrofurantoin failure in males with an uncomplicated urinary tract infection: a primary care observational cohort study
por: Platteel, Tamara N, et al.
Publicado: (2023)

Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management
por: Kaye, Keith S, et al.
Publicado: (2021)

Fosfomycin vs Ertapenem for Outpatient Treatment of Complicated Urinary Tract Infections: A Multicenter, Retrospective Cohort Study
por: Wald-Dickler, Noah, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario
por: Perrault, Louise, et al.
Publicado: (2017)

Efficacy and Safety of Gepotidacin as Treatment of Uncomplicated Urogenital Gonorrhea (EAGLE-1): Design of a Randomized, Comparator-Controlled, Phase 3 Study
por: Perry, Caroline R., et al.
Publicado: (2023)

Reproductive toxicology. Nitrofurantoin.
Publicado: (1997)

Tailored implementation for chronic diseases (TICD): A project protocol
por: Wensing, Michel, et al.
Publicado: (2011)

Assessing family medicine trainees – what can we learn from the European neighbours?
por: Flum, Elisabeth, et al.
Publicado: (2015)

Patient safety initiatives in Central and Eastern Europe: A mixed methods approach by the LINNEAUS collaboration on patient safety in primary care
por: Godycki-Cwirko, Maciek, et al.
Publicado: (2015)

Impact of an Antimicrobial Stewardship Bundle for Uncomplicated Gram-Negative Bacteremia
por: Erickson, Reaghan M, et al.
Publicado: (2019)

Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial
por: Gágyor, Ildikó, et al.
Publicado: (2015)

Susceptibility pattern of oral antimicrobials in uncomplicated UTI: Does fosfomycin still stand effective?
por: Batra, Priyam, et al.
Publicado: (2020)

Impact of Fluoroquinolone Susceptibility Suppression on Discharge Prescribing for Acute Uncomplicated Cystitis
por: Hayden, Dillon A, et al.
Publicado: (2023)

P19 Burden of illness and costs among female patients with uncomplicated urinary tract infection in England
por: Wilcox, Mark, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5leaavjjtp9kj3ui5odi7h2asm